申请人:EGIS Gyogyszergyar
公开号:US04778811A1
公开(公告)日:1988-10-18
It has been found that 2-methyl-thiazolo[4,5-c]quinoline and pharmaceutically acceptable acid addition salts and hydrates thereof possess valuable central nervous depressive properties being different from those of benzodiazepines. The invention relates to pharmaceutical compositions comprising as active ingredient 2-methyl-thiazolo[4,5-c]quinoline of the Formula I ##STR1## or a pharmaceutically acceptable acid addition salt or hydrate thereof.
已发现2-甲基噻唑并[4,5-c]喹啉及其药学上可接受的酸盐和水合物具有有价值的中枢神经抑制特性,与苯二氮平类药物不同。本发明涉及包括2-甲基噻唑并[4,5-c]喹啉的药物组合物作为活性成分,其化学式为I ##STR1## 或其药学上可接受的酸盐或水合物。